Hi Nippy, Interesting in that NOX sounds like a different way of tackling it. Certainly there are others that are progressing well...we have no experience directly in this area. Just alluding to the point there is some evidence that we may do some work in this huge area one day...don't discount us in the area of cancer though we could be many years way from tacking it seriously. For now our focus is solely on OA and MPS as main indications and RRV/Chikungunya to some extent as well.
PAR and ... no way... it can’t be, page-11
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |